These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22027696)

  • 1. A 71-gene signature of TRAIL sensitivity in cancer cells.
    Chen JJ; Knudsen S; Mazin W; Dahlgaard J; Zhang B
    Mol Cancer Ther; 2012 Jan; 11(1):34-44. PubMed ID: 22027696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
    Zhang Y; Zhang B
    Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells.
    Zuo C; Sheng X; Liu Z; Ma M; Xiong S; Deng H; Li S; Yang D; Wang X; Xiao H; Quan H; Xia M
    Tumour Biol; 2017 Jun; 39(6):1010428317710410. PubMed ID: 28639887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
    Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
    Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8.
    Häcker S; Dittrich A; Mohr A; Schweitzer T; Rutkowski S; Krauss J; Debatin KM; Fulda S
    Oncogene; 2009 Sep; 28(35):3097-110. PubMed ID: 19597472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-acting gene networks predict TRAIL responsiveness of tumour cells with high accuracy.
    O'Reilly P; Ortutay C; Gernon G; O'Connell E; Seoighe C; Boyce S; Serrano L; Szegezdi E
    BMC Genomics; 2014 Dec; 15(1):1144. PubMed ID: 25527049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.
    Yang X; Merchant MS; Romero ME; Tsokos M; Wexler LH; Kontny U; Mackall CL; Thiele CJ
    Cancer Res; 2003 Mar; 63(5):1122-9. PubMed ID: 12615731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells.
    Zhang X; Zhang X; Hu S; Zheng M; Zhang J; Zhao J; Zhang X; Yan B; Jia L; Zhao J; Wu K; Yang A; Zhang R
    Nucleic Acids Res; 2017 Jun; 45(10):5930-5944. PubMed ID: 28459998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
    El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
    J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
    Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
    Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
    Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
    Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U
    Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
    Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
    Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
    Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
    Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of TNF-related apoptosis-inducing ligand (TRAIL) induction in interferon gamma-mediated apoptosis in Ewing tumor cells.
    Abadie A; Wietzerbin J
    Ann N Y Acad Sci; 2003 Dec; 1010():117-20. PubMed ID: 15033706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma.
    Yang X; Thiele CJ
    Cancer Lett; 2003 Jul; 197(1-2):137-43. PubMed ID: 12880973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-apoptotic signaling induced by Retinoic acid and dsRNA is under the control of Interferon Regulatory Factor-3 in breast cancer cells.
    Bernardo AR; Cosgaya JM; Aranda A; Jiménez-Lara AM
    Apoptosis; 2017 Jul; 22(7):920-932. PubMed ID: 28409399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.
    van Geelen CM; de Vries EG; Le TK; van Weeghel RP; de Jong S
    Br J Cancer; 2003 Jul; 89(2):363-73. PubMed ID: 12865931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.